- Home
- SOHO vs PYPD Comparison
SOHO vs PYPD Comparison
Compare SOHO & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHO
- PYPD
- Stock Information
- Founded
- SOHO 2004
- PYPD 2008
- Country
- SOHO United States
- PYPD Israel
- Employees
- SOHO N/A
- PYPD N/A
- Industry
- SOHO Real Estate Investment Trusts
- PYPD Medical/Dental Instruments
- Sector
- SOHO Real Estate
- PYPD Health Care
- Exchange
- SOHO Nasdaq
- PYPD Nasdaq
- Market Cap
- SOHO 21.5M
- PYPD 22.1M
- IPO Year
- SOHO 2004
- PYPD 2020
- Fundamental
- Price
- SOHO $0.86
- PYPD $3.24
- Analyst Decision
- SOHO Hold
- PYPD Strong Buy
- Analyst Count
- SOHO 1
- PYPD 2
- Target Price
- SOHO $1.50
- PYPD $10.50
- AVG Volume (30 Days)
- SOHO 49.3K
- PYPD 47.5K
- Earning Date
- SOHO 03-05-2025
- PYPD 02-12-2025
- Dividend Yield
- SOHO N/A
- PYPD N/A
- EPS Growth
- SOHO N/A
- PYPD N/A
- EPS
- SOHO N/A
- PYPD N/A
- Revenue
- SOHO $179,860,606.00
- PYPD N/A
- Revenue This Year
- SOHO N/A
- PYPD N/A
- Revenue Next Year
- SOHO $0.70
- PYPD N/A
- P/E Ratio
- SOHO N/A
- PYPD N/A
- Revenue Growth
- SOHO 3.98
- PYPD N/A
- 52 Week Low
- SOHO $0.81
- PYPD $2.37
- 52 Week High
- SOHO $1.54
- PYPD $7.00
- Technical
- Relative Strength Index (RSI)
- SOHO 37.81
- PYPD 53.50
- Support Level
- SOHO $0.81
- PYPD $3.06
- Resistance Level
- SOHO $0.93
- PYPD $3.33
- Average True Range (ATR)
- SOHO 0.06
- PYPD 0.22
- MACD
- SOHO -0.00
- PYPD 0.03
- Stochastic Oscillator
- SOHO 28.37
- PYPD 81.35
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.